Additional Details

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

IU Health Ball Memorial Physicians Pulmonary and Critical Care Medicine
Muncie, IN 47303-3432